Company: BNBX
Filing Date: 2025-10-30
Form Type: S-1
Source: 0001104659-25-103871
Chunk: 145

Company: BNB PLUS CORP.
Filing Date: 2025-10-30
Form: S-1
Chunk 145
---
ott Will & Schulte LLP, New York, New York.

<div align='center'>Where you can find more information</div>

This prospectus is a part of the registration statement on Form S-1 we filed with the SEC under the Securities Act and does not contain all the information set forth in the registration statement. Whenever a reference is made in this prospectus to any of our contracts, agreements or other documents, the reference may not be complete and you should refer to the exhibits that are a part of the registration statement or the exhibits to the reports for a copy of such contract, agreement or other document. Because we are subject to the information and reporting requirements of the Exchange Act, we file or furnish, as applicable, annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC also maintains a web site that contains reports, proxy and information statements and other information regarding companies, such as ours, that file documents electronically with the SEC. The website address is www.sec.gov. The information on the SEC’s website is not part of this prospectus, and any references to this website or any other website are inactive textual references only. Our Internet address is www.adnas.com. The information found on our website is not part of this prospectus and investors should not rely on any such information in deciding whether to invest.

<div align='center'>85</div>

APPLIED DNA SCIENCES, INC. AND SUBSIDIARIES INDEX TO FINANCIAL STATEMENTS Audited Consolidated Financial Statements

|                                                                                              | Page |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 688)                       | F-2  |
| ​                                                                                            | ​    |
| Consolidated Balance Sheets as of September 30, 2024 and 2023                                | F-3  |
| ​                                                                                            | ​    |
| Consolidated Statements of Operations for the Fiscal Years Ended September 30, 2024 and 2023 | F-4  |
| ​                                                                                            | ​    |
| Consolidated Statements of Equity for the Fiscal Years Ended September 30, 2024 and 2023     | F-5  |
| ​                                                                                            | ​    |
| Consolidated Statements of Cash Flows for the Fiscal Years Ended September 30, 2024 and 2023 | F-6  |
| ​                                                                                            | ​    |
| Notes to Consolidated Financial Statements                                                   | F-7  |

Unaudited Consolidated Financial Statements

| Consolidated Balance